Shenzhen Kangtai Biological Products Co., Ltd. engages in the manufacture, sale, and research and development of human vaccines. Its products include cell free haemophilus infuenzae type b vaccine, measles rubella vaccine, haemophilus influenzae type b conjugate vaccine, recombinant hepatitis B vaccine, and liver vaccine. The company was founded on September 8, 1992 and is headquartered in Shenzhen, China.